Ballard Spahr·REAL ESTATE / CMBS

Life Sciences Real Estate Demand Pivots to US Manufacturing Sites

While demand for R&D lab space has fallen, investment in domestic pharmaceutical manufacturing facilities is rising, creating opportunities beyond traditional leasing.

life-sciencesreal-estate-developmentpharmaceuticalsmanufacturingonshoringcommercial-real-estate
Read the original firm alert → Wednesday, September 23, 2026

Stay ahead

Join the digest.

One email when the daily AmLaw 100 briefing ships. No noise, no pitch decks — just the grade 4–5 signal.